Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08RBW
|
|||
| Drug Name |
LY900014
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11] | Phase 3 | [1] | |
| Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Phase 1 | [2], [3] | ||
| Company |
Eli Lilly Indianapolis, IN
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04605991) A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.